|
Market Closed -
OTC Markets
13:27:45 2025-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -50.00% |
|
-50.00% | - |
Company Valuation: Biostax Corp.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1.954 | 2.974 | 6.835 | 1.441 | 49.83 | 6.11 |
| Change | - | 52.18% | 129.81% | -78.92% | 3,358.09% | -87.74% |
| Enterprise Value (EV) 1 | 7.136 | 8.515 | 9.67 | 2.088 | 50.37 | 7.264 |
| Change | - | 19.31% | 13.57% | -78.41% | 2,312.7% | -85.58% |
| P/E | -0.24x | -0.88x | 4.35x | 7.87x | -6x | -3.65x |
| PBR | -0.17x | -0.22x | -0.59x | -0.18x | -19.8x | -1.6x |
| PEG | - | 0x | -0x | -0.1x | 0x | 0x |
| Capitalization / Revenue | 17.2x | - | - | - | - | - |
| EV / Revenue | 62.9x | - | - | - | - | - |
| EV / EBITDA | -1.75x | -3x | -10.9x | -2.83x | - | -5.08x |
| EV / EBIT | -1.75x | -3x | -10.9x | -2.83x | -43.3x | -4.89x |
| EV / FCF | -3.3x | 84.8x | -83x | -1x | -8.65x | -20.3x |
| FCF Yield | -30.3% | 1.18% | -1.2% | -100% | -11.6% | -4.93% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -19.03 | -7.423 | 3.334 | 0.38 | -0.1 | -0.02 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 0.1135 | - | - | - | - | - |
| EBITDA 1 | -4.083 | -2.836 | -0.8864 | -0.7375 | - | -1.431 |
| EBIT 1 | -4.085 | -2.838 | -0.887 | -0.7382 | -1.163 | -1.485 |
| Net income 1 | -8.175 | -3.397 | 1.589 | 3.586 | -3.536 | -1.651 |
| Net Debt 1 | 5.182 | 5.54 | 2.835 | 0.647 | 0.546 | 1.154 |
| Reference price 2 | 4.500000 | 6.500000 | 14.510000 | 2.990000 | 0.600000 | 0.073035 |
| Nbr of stocks (in thousands) | 434 | 458 | 471 | 482 | 83,046 | 83,658 |
| Announcement Date | 4/16/19 | 5/14/20 | 4/15/21 | 3/18/22 | 4/10/23 | 4/16/24 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 21.65K | ||
| 17.13x | 6.55x | 12.55x | 1.74% | 65.56B | ||
| 32.67x | 8.73x | 28.87x | 0.07% | 60.41B | ||
| 38.83x | 6.91x | 20.67x | 0.84% | 55.76B | ||
| 44.13x | 6.17x | 29.36x | -.--% | 46.98B | ||
| 34.55x | 3.29x | 14.19x | -.--% | 43.63B | ||
| 36.23x | 8.96x | 23.37x | 0.36% | 36.7B | ||
| -19.98x | 53.61x | -21.71x | -.--% | 36.09B | ||
| 41.91x | 8.08x | 27.1x | -.--% | 32.9B | ||
| -74.98x | 14.21x | -76.38x | -.--% | 26.96B | ||
| Average | 16.72x | 12.95x | 6.45x | 0.33% | 40B | |
| Weighted average by Cap. | 21.75x | 11.58x | 11.42x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BTAX Stock
- Valuation Biostax Corp.
Select your edition
All financial news and data tailored to specific country editions
















